Clinical Trial: A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070297) titled 'A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses' on Dec. 23, 2024.

Brief Summary: This study is a single-arm, open-label clinical study. A total of 12 patients with allergic asthma are planned to be enrolled to receive XKH001 600 mg Q4W administration for the assessment of the safety, immunogenicity, PK, and PD characteristics of multiple doses.

Study Start Date: Dec. 26, 2023

Study Type: INTERVENTIONAL

Condition: Asthma Patients

Intervention: DRUG: XKH001 Injection

Dosage: 600 mg Q4W (D1, D29 and D57) Method of administration: the drug will be administered by SC ...